Lev Facher covers the U.S. addiction and overdose crisis. Drug policy was largely a backburner issue in 2025. Despite the ambitions of some moderate or right-leaning activists, and an apparent passion ...
On September 30, 2025, the Centers for Medicare & Medicaid Services (CMS) published the final guidance for the third cycle of the Medicare Drug Price Negotiation Program, initial price applicability ...
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.
Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results